. | Control Group (n = 34) . | Endometriosis-Hysterectomy Group (n = 38) . | Endometrioma-Cystectomy Group (n = 25) . |
---|---|---|---|
Age, ya | 37.4 ± 3.7 | 39.1 ± 5.5 | 25.3 ± 5.7b |
Number of deliveriesa | 1.9 ± 0.6 | 1.2 ± 0.8c | 0 |
Menstrual phases | |||
Proliferative | 14d | 15d | 14e |
Secretory | 20d | 23d | 11e |
Early secretory | 4d | 5d | |
Midsecretory | 6d | 8d | |
Late secretory | 10d | 10d | |
AFS Classification of endometriosis | |||
Stage III | 12 | 10 | |
Stage IV | 26 | 15 | |
Serum CA-125 levelf | 71.8 ± 13.1 | 70.5 ± 16.6 |
. | Control Group (n = 34) . | Endometriosis-Hysterectomy Group (n = 38) . | Endometrioma-Cystectomy Group (n = 25) . |
---|---|---|---|
Age, ya | 37.4 ± 3.7 | 39.1 ± 5.5 | 25.3 ± 5.7b |
Number of deliveriesa | 1.9 ± 0.6 | 1.2 ± 0.8c | 0 |
Menstrual phases | |||
Proliferative | 14d | 15d | 14e |
Secretory | 20d | 23d | 11e |
Early secretory | 4d | 5d | |
Midsecretory | 6d | 8d | |
Late secretory | 10d | 10d | |
AFS Classification of endometriosis | |||
Stage III | 12 | 10 | |
Stage IV | 26 | 15 | |
Serum CA-125 levelf | 71.8 ± 13.1 | 70.5 ± 16.6 |
. | Control Group (n = 34) . | Endometriosis-Hysterectomy Group (n = 38) . | Endometrioma-Cystectomy Group (n = 25) . |
---|---|---|---|
Age, ya | 37.4 ± 3.7 | 39.1 ± 5.5 | 25.3 ± 5.7b |
Number of deliveriesa | 1.9 ± 0.6 | 1.2 ± 0.8c | 0 |
Menstrual phases | |||
Proliferative | 14d | 15d | 14e |
Secretory | 20d | 23d | 11e |
Early secretory | 4d | 5d | |
Midsecretory | 6d | 8d | |
Late secretory | 10d | 10d | |
AFS Classification of endometriosis | |||
Stage III | 12 | 10 | |
Stage IV | 26 | 15 | |
Serum CA-125 levelf | 71.8 ± 13.1 | 70.5 ± 16.6 |
. | Control Group (n = 34) . | Endometriosis-Hysterectomy Group (n = 38) . | Endometrioma-Cystectomy Group (n = 25) . |
---|---|---|---|
Age, ya | 37.4 ± 3.7 | 39.1 ± 5.5 | 25.3 ± 5.7b |
Number of deliveriesa | 1.9 ± 0.6 | 1.2 ± 0.8c | 0 |
Menstrual phases | |||
Proliferative | 14d | 15d | 14e |
Secretory | 20d | 23d | 11e |
Early secretory | 4d | 5d | |
Midsecretory | 6d | 8d | |
Late secretory | 10d | 10d | |
AFS Classification of endometriosis | |||
Stage III | 12 | 10 | |
Stage IV | 26 | 15 | |
Serum CA-125 levelf | 71.8 ± 13.1 | 70.5 ± 16.6 |
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.